Shashikant Srivastava

27PUBLICATIONS
26CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsRegenerative medicine (incl. stem cells)Medical bacteriologyPharmacogenomicsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Apr 10, 2026
Novel regimens for treatment of Mycobacterium avium lung disease based on advanced in vitro systems and the mathematics of basis functions.

Shashikant Srivastava, Sanjay Singh, Gunavanthi D Boorgula

|Apr 09, 2026
Sulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for Mycobacterium abscessus lung disease.

Sanjay Singh, Avneesh Shrivastava, Gunavanthi D Boorgula

|Dec 19, 2025
Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease.

Tawanda Gumbo, Gunavanthi D Boorgula, Shashikant Srivastava

|Dec 18, 2025
Buruli ulcer.

Rie R Yotsu, Rachel E Simmonds, Dziedzom K de Souza

|Dec 10, 2025
Eravacycline pharmacokinetics/pharmacodynamics in the hollow fiber system model of Mycobacterium abscessus lung disease.

Sanjay Singh, Avneesh Shrivastava, Gunavanthi D Boorgula

Pageof 5